RU2017137502A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017137502A3 RU2017137502A3 RU2017137502A RU2017137502A RU2017137502A3 RU 2017137502 A3 RU2017137502 A3 RU 2017137502A3 RU 2017137502 A RU2017137502 A RU 2017137502A RU 2017137502 A RU2017137502 A RU 2017137502A RU 2017137502 A3 RU2017137502 A3 RU 2017137502A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/812—Breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/828—Stomach
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16141—Use of virus, viral particle or viral elements as a vector
- C12N2760/16142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015901375A AU2015901375A0 (en) | 2015-04-17 | A vaccine composition and uses thereof | |
| AU2015901375 | 2015-04-17 | ||
| PCT/AU2016/050275 WO2016164980A1 (en) | 2015-04-17 | 2016-04-15 | A vaccine composition and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017137502A RU2017137502A (ru) | 2019-05-17 |
| RU2017137502A3 true RU2017137502A3 (cg-RX-API-DMAC10.html) | 2019-09-16 |
| RU2726411C2 RU2726411C2 (ru) | 2020-07-14 |
Family
ID=57125491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017137502A RU2726411C2 (ru) | 2015-04-17 | 2016-04-15 | Вакцинная композиция и ее применения |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10532090B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3283105B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6957448B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102372615B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN108025061B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2016250289B2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2908071T3 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ736194A (cg-RX-API-DMAC10.html) |
| RS (1) | RS63080B1 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2726411C2 (cg-RX-API-DMAC10.html) |
| SG (1) | SG11201708247XA (cg-RX-API-DMAC10.html) |
| TW (1) | TWI740823B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2016164980A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3723792A2 (en) * | 2017-12-11 | 2020-10-21 | Medizinische Universität Wien | A method of producing a vaccine composition and uses thereof |
| JP2021512966A (ja) * | 2018-02-07 | 2021-05-20 | イミュジーン、リミテッドＩｍｕｇｅｎｅ Ｌｉｍｉｔｅｄ | ワクチン組成物およびその使用 |
| CA3202133A1 (en) * | 2020-12-16 | 2022-06-23 | Martin Gohlke | Method for quantifying cpg-containing oligonucleotides in formulations comprising alum |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0739984A1 (en) * | 1995-04-26 | 1996-10-30 | San Tumorforschungs-Gmbh | Bivalent polypeptides containing at least two domains |
| GB9808932D0 (en) * | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| US7060284B1 (en) * | 1999-08-03 | 2006-06-13 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| EP1236740B1 (de) | 2001-02-28 | 2012-07-18 | Bio Life Science Forschungs- und Entwicklungsges.m.b.H. | Vakzine gegen Krebserkrankungen, die mit dem HER-2/neu Onkogen assoziiert sind |
| WO2005021710A2 (en) * | 2003-06-02 | 2005-03-10 | University Of Miami | Chimeric molecules and methods of use |
| ES2348312T3 (es) | 2006-04-13 | 2010-12-02 | Bio Life Science Forschungs- Und Entwicklungsges.M.B.H. | Vacuna her-2/neu a base de múltiples péptidos. |
| EP2292258A1 (en) * | 2009-08-18 | 2011-03-09 | Pevion Biotech Ltd. | Multiepitope vaccine for Her2/neu-associated cancers |
| EP2659906A1 (en) * | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| SI2668959T1 (sl) * | 2012-05-31 | 2015-03-31 | Innavirvax Genopole Enterprises | Imunogenske spojine, ki vsebujejo HIV gp41 peptid, spojen z nosilnim proteinom CRM197 |
| US20170196953A1 (en) * | 2014-07-07 | 2017-07-13 | Duke University | VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME |
-
2016
- 2016-04-15 CN CN201680029118.4A patent/CN108025061B/zh active Active
- 2016-04-15 RU RU2017137502A patent/RU2726411C2/ru active
- 2016-04-15 RS RS20220204A patent/RS63080B1/sr unknown
- 2016-04-15 US US15/316,868 patent/US10532090B2/en active Active
- 2016-04-15 KR KR1020177032987A patent/KR102372615B1/ko active Active
- 2016-04-15 ES ES16779340T patent/ES2908071T3/es active Active
- 2016-04-15 NZ NZ736194A patent/NZ736194A/en unknown
- 2016-04-15 EP EP16779340.5A patent/EP3283105B1/en active Active
- 2016-04-15 WO PCT/AU2016/050275 patent/WO2016164980A1/en not_active Ceased
- 2016-04-15 AU AU2016250289A patent/AU2016250289B2/en active Active
- 2016-04-15 SG SG11201708247XA patent/SG11201708247XA/en unknown
- 2016-04-15 JP JP2018505505A patent/JP6957448B2/ja active Active
- 2016-04-15 TW TW105111976A patent/TWI740823B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| US10532090B2 (en) | 2020-01-14 |
| EP3283105B1 (en) | 2022-01-26 |
| RS63080B1 (sr) | 2022-04-29 |
| RU2017137502A (ru) | 2019-05-17 |
| TWI740823B (zh) | 2021-10-01 |
| HK1248536A1 (zh) | 2018-10-19 |
| EP3283105A4 (en) | 2018-12-19 |
| BR112017021981A2 (pt) | 2018-07-10 |
| TW201705978A (zh) | 2017-02-16 |
| KR102372615B1 (ko) | 2022-03-08 |
| CN108025061A (zh) | 2018-05-11 |
| AU2016250289B2 (en) | 2017-03-02 |
| JP2018511659A (ja) | 2018-04-26 |
| AU2016250289A1 (en) | 2017-01-05 |
| KR20180003560A (ko) | 2018-01-09 |
| JP6957448B2 (ja) | 2021-11-02 |
| ES2908071T3 (es) | 2022-04-27 |
| NZ736194A (en) | 2022-08-26 |
| RU2726411C2 (ru) | 2020-07-14 |
| SG11201708247XA (en) | 2017-11-29 |
| EP3283105A1 (en) | 2018-02-21 |
| WO2016164980A1 (en) | 2016-10-20 |
| CN108025061B (zh) | 2022-02-15 |
| US20170119867A1 (en) | 2017-05-04 |